XCELL THERAPEUTICS INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,330 KRW | 0.00% |
|
0.00% | 0.00% |
| 10:59am | Xcell Therapeutics Shares Fall 4.7% Below Offering Price on Kosdaq Debut | MT |
| 07-08 | Xcell Therapeutics Inc. has completed an IPO in the amount of KRW 16.18 billion. | CI |
XCell Therapeutics Inc is a Korea-based company mainly engaged in the development and manufacture of cell culture medium. The Company mainly conducts research, development and production of cell culture media, a material for biopharmaceuticals.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 64.98M | |
| +62.87% | 856B | |
| +38.95% | 631B | |
| -3.99% | 359B | |
| +16.20% | 325B | |
| +8.85% | 297B | |
| +5.89% | 234B | |
| +16.53% | 226B | |
| +15.51% | 177B | |
| +1.77% | 165B |
- Stock Market
- Equities
- A373110 Stock
- News Xcell Therapeutics Inc.
- Xcell Therapeutics Shares Fall 4.7% Below Offering Price on Kosdaq Debut
